Cost-effectiveness of expanded antiviral treatment for chronic hepatitis B virus infection in China: an economic evaluation.
Zhang S, Wang C, Liu B, Lu QB, Shang J, Zhou Y, Jia J, Xu X, Rao H, Han B, Zhao T, Chen L, Xie M, Cui J, Du J, Zeng J, Huang N, Liu Y, Zhang L, Zhuang H, Cui F.
Zhang S, et al. Among authors: huang n.
Lancet Reg Health West Pac. 2023 Mar 9;35:100738. doi: 10.1016/j.lanwpc.2023.100738. eCollection 2023 Jun.
Lancet Reg Health West Pac. 2023.
PMID: 37424693
Free PMC article.